Ernexa Therapeutics Inc. Taxes Payable, Current
Ernexa Therapeutics Inc. (ERNA) had Taxes Payable, Current of $4.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-06
- 2026-03-31: Taxes Payable, Current $4.00K.
- 2025-12-31: Taxes Payable, Current $3.00K.
- 2025-09-30: Taxes Payable, Current $17.00K.
- 2025-06-30: Taxes Payable, Current $11.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $3.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $11.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $11.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $3.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $18.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $2.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $7.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |